Stay updated on GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page.

Latest updates to the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe sponsor listing changed from Gossamer Bio Inc. to Gossamer Bio USA, Inc., and the page revision moved from v3.6.3 to v3.6.4, indicating administrative updates to the study record.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedRevision: v3.6.3 update has replaced v3.6.2 on the page, signaling a new software build for the site. This is a software build update and does not indicate changes to the study content or page data.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2, indicating a newer build of the page is now in effect. This appears to be a minor technical update rather than a change to study data or user-facing content.SummaryDifference0.0%

- Check57 days agoChange DetectedRecruitment status updated to indicate no further participants are being sought. New support pages (How to Read a Study Record, Common Questions, How to Join a Study) were added, the Intervention/Treatment heading was reformatted, and the site revision was updated to v3.6.0.SummaryDifference0.4%

- Check65 days agoChange DetectedThe page footer now shows Revision: v3.5.5, replacing v3.5.4. This is a minor publishing update and does not affect the study details.SummaryDifference0.0%

- Check86 days agoChange DetectedThe revision is updated from v3.5.3 to v3.5.4, indicating a software update. No user-facing changes to study content are evident.SummaryDifference0.0%

Stay in the know with updates to GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page.